• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性黑色素瘤Breslow厚度的临床关联

Clinical correlates of Breslow thickness of malignant melanoma.

作者信息

Osborne J E, Hutchinson P E

机构信息

Department of Dermatology, Leicester Royal Infirmary, Leicester, LE1 5WW U.K.

出版信息

Br J Dermatol. 2001 Mar;144(3):476-83. doi: 10.1046/j.1365-2133.2001.04071.x.

DOI:10.1046/j.1365-2133.2001.04071.x
PMID:11260002
Abstract

BACKGROUND

Breslow thickness is a major predictor of prognosis in cutaneous malignant melanoma (MM) and patients continue to present with thick lesions, which have a poorer prognosis.

OBJECTIVES

To investigate correlations of Breslow thickness with demographic variables, tumour site, clinical features, false negative diagnostic rate and clinic of primary referral.

METHODS

Data were obtained from the records of 738 patients with histologically diagnosed cutaneous MM. Tumours included were in situ and invasive MM and lentigo maligna melanoma. In view of the skewed distribution of MM thickness, categories of MM thickness were used for analysis, using the commonly applied cut-offs of 0.75, 1.5 and 3.5 mm. The variables investigated were particularly associated with changes in the proportion of the thickest group, 'thick' MMs. The proportion of this thickness category is proposed as an appropriate and sensitive variable for the investigation of correlations with MM thickness. Thickness >/= 1.5 mm has also been considered in view of its prognostic significance.

RESULTS

Results were similar for the two thickness groups, but more significant for the thick group. The previously described correlations of tumour thickness and increasing age (P < 0.00001) and location on head and neck (P = 0.0002), together with the independence of these variables, have been confirmed. The correlation with male gender was also confirmed but this was weak (P = 0.05). Novel findings were correlations of Breslow thickness with all features of the seven-point checklist (P varying from P = 0.01 to P < 0.00001) and tumour elevation (P < 0.00001). In general in the seven-point checklist, the absence of the major features (except variation in size) (P < 0.00001) and presence of minor features (except altered sensation) (P varying from P = 0.004 to P < 0.00001) were strongly associated with thick MMs. These results for tumour thickness are a further argument for retention of the minor features of the seven-point checklist. False negative diagnosis was found to be correlated with tumour thickness (P < 0.02) but this relationship was lost on multivariate analysis with inclusion of the clinical features. MM thickness was highly correlated with primary referral clinic (P < 0.00001). Only approximately 8% of MMs presenting to the Pigmented Lesion Clinic (PLC) were thick, while the proportion presenting to general dermatology was about three times greater and to plastic surgery about five times greater. This was maintained on multivariate analysis, including all other variables and, therefore, there must be other determining factors of referral not examined in the study. Conclusion MM thickness is associated with increasing age, male gender, location on the head and neck, all features of the seven-point checklist, tumour elevation and referral to the PLC. It is important to investigate further the reasons for general practitioner referral of different thickness MM to different types of clinic, as referral to clinics other than the PLC results in delay in the first hospital appointment, and it is now apparent that thicker lesions are disproportionately affected.

摘要

背景

Breslow厚度是皮肤恶性黑色素瘤(MM)预后的主要预测指标,仍有患者出现厚度较大的病灶,其预后较差。

目的

研究Breslow厚度与人口统计学变量、肿瘤部位、临床特征、假阴性诊断率及初次转诊科室之间的相关性。

方法

从738例经组织学诊断为皮肤MM的患者记录中获取数据。纳入的肿瘤包括原位和浸润性MM以及恶性雀斑样痣黑色素瘤。鉴于MM厚度的分布呈偏态,采用MM厚度类别进行分析,使用常用的0.75、1.5和3.5mm截断值。所研究的变量特别与最厚组(“厚”MM)比例的变化相关。该厚度类别的比例被认为是用于研究与MM厚度相关性的合适且敏感的变量。鉴于其预后意义,也考虑了厚度≥1.5mm的情况。

结果

两个厚度组的结果相似,但厚组的结果更显著。先前描述的肿瘤厚度与年龄增长(P<0.00001)以及头颈部位置(P = 0.0002)的相关性,以及这些变量的独立性得到了证实。与男性的相关性也得到了证实,但较弱(P = 0.05)。新发现是Breslow厚度与七点检查表的所有特征(P值从P = 0.01到P<0.00001)以及肿瘤隆起(P<0.00001)相关。总体而言,在七点检查表中,主要特征(除大小变化外)的缺失(P<0.00001)和次要特征(除感觉改变外)的存在(P值从P = 0.004到P<0.00001)与厚MM密切相关。这些肿瘤厚度的结果进一步支持保留七点检查表的次要特征。发现假阴性诊断与肿瘤厚度相关(P<0.02),但在纳入临床特征进行多变量分析时这种关系消失了。MM厚度与初次转诊科室高度相关(P<0.00001)。就诊于色素沉着病变诊所(PLC)的MM中只有约8%是厚的,而就诊于普通皮肤科的比例约为其三倍,就诊于整形外科的比例约为其五倍。在包括所有其他变量的多变量分析中这一情况得以维持,因此,研究中未考察的转诊必定存在其他决定因素。结论MM厚度与年龄增长、男性、头颈部位置、七点检查表的所有特征、肿瘤隆起以及转诊至PLC相关。进一步研究全科医生将不同厚度的MM转诊至不同类型科室的原因很重要,因为转诊至PLC以外的科室会导致首次医院预约延迟,现在很明显较厚的病灶受到的影响不成比例。

相似文献

1
Clinical correlates of Breslow thickness of malignant melanoma.恶性黑色素瘤Breslow厚度的临床关联
Br J Dermatol. 2001 Mar;144(3):476-83. doi: 10.1046/j.1365-2133.2001.04071.x.
2
Comparison of diagnostic accuracy for cutaneous malignant melanoma between general dermatology, plastic surgery and pigmented lesion clinics.普通皮肤科、整形外科和色素沉着病变诊所对皮肤恶性黑色素瘤诊断准确性的比较。
Br J Dermatol. 2003 Feb;148(2):252-8. doi: 10.1046/j.1365-2133.2003.05154.x.
3
Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.西班牙巴伦西亚1571例皮肤恶性黑色素瘤的临床病理分析:与肿瘤厚度相关的因素
Acta Derm Venereol. 2006;86(1):50-6. doi: 10.2340/00015555-0004.
4
[Survival analysis in patients with cutaneous malignant melanoma].[皮肤恶性黑色素瘤患者的生存分析]
Srp Arh Celok Lek. 1997 May-Jun;125(5-6):132-7.
5
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.体内反射共聚焦显微镜在黑素细胞性病变分析中的作用
Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67.
6
A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.一项回顾性观察研究,比较仅接受切除术治疗的原发性皮肤恶性黑色素瘤患者与先行切除活检再行更广泛局部切除的患者。
Br J Dermatol. 2004 Mar;150(3):523-30. doi: 10.1111/j.1365-2133.2004.05849.x.
7
Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.头颈部黑色素瘤是一种独特的疾病实体吗?一项基于临床登记的对5702例黑色素瘤患者的比较研究。
Br J Dermatol. 2006 Oct;155(4):771-7. doi: 10.1111/j.1365-2133.2006.07455.x.
8
Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.从20世纪80年代中期到90年代后期黑色素瘤厚度的临床和人口统计学相关因素的变化。
Eur J Dermatol. 2003 Jan-Feb;13(1):72-5.
9
Factors associated with a high tumour thickness in patients with melanoma.黑色素瘤患者肿瘤厚度高的相关因素。
Br J Dermatol. 2007 May;156(5):938-44. doi: 10.1111/j.1365-2133.2007.07805.x. Epub 2007 Mar 23.
10
Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.恶性雀斑样痣黑色素瘤与头颈部其他组织发生类型恶性黑色素瘤的比较。苏格兰黑色素瘤研究小组。
Br J Cancer. 1996 Apr;73(7):940-4. doi: 10.1038/bjc.1996.168.

引用本文的文献

1
Association of Plasma Lipid Patterns and LDL Cholesterol Levels with Breslow Thickness and Ulceration in Melanoma Patients.黑色素瘤患者血浆脂质模式和低密度脂蛋白胆固醇水平与 Breslow 厚度及溃疡形成的关联
Int J Mol Sci. 2025 Feb 17;26(4):1716. doi: 10.3390/ijms26041716.
2
An analysis of lactate dehydrogenase (LDH) levels in advanced stage IV melanoma of the skin: prognostic capabilities and demographic variability.皮肤晚期IV期黑色素瘤中乳酸脱氢酶(LDH)水平分析:预后能力及人口统计学变异性
Arch Dermatol Res. 2023 May;315(4):799-806. doi: 10.1007/s00403-022-02425-0. Epub 2022 Nov 1.
3
A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants.
一项针对黑色素瘤 Breslow 厚度的全基因组综合分析确定了 CDC42 与 SCIN 基因变异之间的相互作用。
Int J Cancer. 2016 Nov 1;139(9):2012-20. doi: 10.1002/ijc.30245. Epub 2016 Jul 23.
4
SOX5 is involved in balanced MITF regulation in human melanoma cells.SOX5参与人类黑色素瘤细胞中MITF的平衡调控。
BMC Med Genomics. 2016 Feb 29;9:10. doi: 10.1186/s12920-016-0170-0.
5
Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.隐蔽部位皮肤黑色素瘤的临床病理特征、维生素D血清水平及预后:最新进展
Med Oncol. 2015 Jan;32(1):451. doi: 10.1007/s12032-014-0451-4. Epub 2014 Dec 17.
6
Mitochondrial haplogroups, control region polymorphisms and malignant melanoma: a study in middle European Caucasians.线粒体单倍群、控制区多态性与恶性黑素瘤:中欧白种人群研究。
PLoS One. 2011;6(12):e27192. doi: 10.1371/journal.pone.0027192. Epub 2011 Dec 9.
7
Bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: a historical cohort study.Bcl-2表达与转移性皮肤黑色素瘤的生存率无关:一项历史性队列研究。
World J Surg Oncol. 2008 Jun 20;6:65. doi: 10.1186/1477-7819-6-65.
8
Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin).皮肤角质形成细胞癌(基底细胞癌和鳞状细胞癌)的治疗延迟与手术缺损大小的关系。
J Invest Dermatol. 2005 Feb;124(2):308-14. doi: 10.1111/j.0022-202X.2004.23546.x.
9
A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma.维生素D受体1A启动子区域的一种新型多态性与恶性黑色素瘤易感性和预后的改变相关。
Br J Cancer. 2004 Aug 16;91(4):765-70. doi: 10.1038/sj.bjc.6602006.